APAP vs. CPAP: What Every Clinician Needs to Know

advertisement
CPAP
vs
What Every Clinician Needs to Know
Carol Ash, DO, MBA, FAASM
Corporate Director of Sleep Medicine
Meridian Health New Jersey
CPAP vs APAP
• What are the different device options
• Understand the operational differences between the two modalities
• Separate the myth from the reality
• What factors to consider when deciding
• Understand unique APAP algorithms for identifying and responding to
respiratory events
• What the studies recommend
• What is the future direction
History Positive Airway Pressure (PAP) Devices
• Introduced in 1953 by Dr. Bjorn Ibsen, an anesthesiologist during
Copenhagen’s polio epidemic, which saw the birth of intensive care
• 1981 Dr. Colin Sullivan introduces the noninvasive application of
positive airway pressure to treat obstructive sleep apnea (OSA) with
the nifty invention of a reversed vacuum machine
Dr. Bjorn Ibsen
Dr. Colin Sullivan
What’s In A Name?
• PAP – Positive Airway Pressure
• CPAP – Continuous Airway Pressure
• Bi-level (BIPAP)
• APAP - Auto-titrating PAP (auto-PAP)
• ASV - Adaptive Servo-Ventilation
PAP Insurance
CPAP will be covered for adults with sleep-disordered breathing if:
• AHI (or RDI) > 15
OR
• AHI (or RDI) > 5 with (“mild, symptomatic”)
• Hypertension
• Stroke
• Sleepiness
• Ischemic heart disease
• Insomnia
• Mood disorders
Physiology of PAP
• Works to splint the airway open and prevent the collapse of the upper
airway
• Greater end-expiratory lung volume and increase in oxygen stores
• Increased tracheal traction to improve upper airway patency
• Lower cardiac after- load and consequent increase in cardiac output
• Decrease venous return
• Cost-effective and one least toxic forms of medical therapy
Negative Consequences PAP
• Increase abdominal muscle effort
• Provoke anxiety
• Cause central apneas by destabilizing breathing
• May eliminate CO2 and reduce arterial PCO2 below the apnea
threshold
• Ventilatory instability characterized by central apneas and periodic breathing.
• Mask interface-related skin changes (abrasions, pressure sores,
contact dermatitis)
• Aerophagia, sinus pain, oral/nasal dryness, tooth decay
CPAP vs APAP
• CPAP continuous pressure set during titration during in house sleep
study or best guess standard treatment OSA
• APAP devices change the treatment pressure based on feedback from
various patient measures such as airflow, pressure fluctuations, or
measures of airway resistance
CPAP
• Constant between inspiration and expiration
• Achieved by a servo-controlled air compressor maintains the airway
pressure as closely to the prescribed pressure despite the pull
(inspiration) and push (exhalation)
• Within an FDA-specified pressure range (for example, ± 1.5 cm H2O of
the set pressure) as a quality-assurance measure
• Error range is generally greater with larger tidal volume (VT) or inspiratory
effort from patient, faster respiratory rate, and at higher RX set pressure
• Allows response to changes in the airway pressure
Auto-titrating PAP (APAP, auto-PAP)
• Built in microprocessors detect and treat OSA
• Self-adjusting, automatic, auto-adjusting, smart CPAP and autotitrating PAP (auto-PAP).
• Purposes:
• Alternative to in-laboratory manual titration
• Achieve lower mean pressures, promote adherence
• Allows PAP changes in response to changes in:
• Severity of OSA , weight, sleep state, body position, alcohol use
• Expanded to detecting SDB, treating central apneas, and
correcting hypoventilation
APAP pressure
changes based
on a patient’s needs
at a specific time
CPAP pressure is
maintained at a
constant, generally
based on a patient’s
In-lab titration
APAP
• Aid in the pressure titration process
• Address possible changes in pressure requirements throughout a
given night and from night to night
• Aid in treatment of OSA when attended CPAP titration has not or
cannot be accomplished
• Improve patient comfort
AASM Current APAP
Recommendations
• Not recommended to:
• Diagnose OSA
• Facilitate split night titration (certain devices can be used during attended)
• Treat:
• CHF
• Significant lung disease (COPD)
• Nocturnal arterial oxyhemoglobin desaturation due to conditions other
than OSA (e.g. OHS)
• Patients who do not snore (includes post palate surgery)
• Central sleep apnea syndromes
APAP Device Technology
• First generation sensors merely measured pressure vibrations that
were caused by snoring
• Next generation able to sense flow-based changes (apnea, hypopnea,
or inspiratory flow limitation) based upon the inspiratory flow
contour (ie, flattening of the inspiratory flow waveform)
Newer Generation Devices
• Can differentiate central from obstructive apneas
• Uses forced oscillation technique / measures compliance changes
• Identify Cheyne-Stokes respiration - detects variation peak flow
• Identify hypoventilation – measures VT or V̇E using calibrated flow
sensors
• Compensates for air leaks - using sophisticated flow-based
algorithms
• Measure upper and lower airway resistance - using forced
oscillation techniques
APAP Titration for Moderate to Severe OSA
• Can be used to identify a single CPAP pressure
• Self-adjusting mode for unattended titration and treatment without
comorbidities (CHF, COPD, central sleep apnea syndromes, or
hypoventilation syndromes)
• When used in titration to set fixed CPAP or being treated with APAP
must have close clinical follow-up for effectiveness and safety
• Symptoms remain - Reevaluate, Standard attended CPAP titration if
symptoms do not resolve or APAP lacks efficacy
APAP
• Intended to be long-term solutions
• Is designed to adjust with patients as their condition and physiology
fluctuate.
• APAP adjusts proactively verses reactively
• Auto Set responds to three separate parameters, based on the degree
of airway blockage: inspiratory flow limitation, snore, and apnea.
Bench Studies & RCTs
• Responses of devices from different manufacturers are quite varied
• Air leak affected the performance
• Some devices were more resilient
• Implications of the effects of air leak
• RCT avoided comorbid conditions
CPAP
APAP
• Equivalent Control of AHI
• At a lower mean pressure
• Improving sleep stage distribution and providing comparable
improvements in daytime sleepiness
• Patients clear preference toward APAP devices and demonstrated
marginally improved compliance
Coughlin
CPAP
APAP
• Both require follow-up with patients to address issues like mask fit,
compliance, and humidity
• Clinically validated algorithms to ensure adequate treatment
• Flow limitation is a precursor to other more severe sleep-disordered
breathing events. An AutoCPAP needs to be able to respond to these
flow-limited events in a timely manner to ensure that the more
severe sleep-disordered breathing events (apnea and hypopnea) are
minimized.”
• Now differentiation between APAP solutions for OSA vs CSA
CPAP
APAP
• Sleepiness
• Twenty-four trials that included over 1,000 patients provided
evidence that APAP reduces sleepiness as measured by ESS by
approximately 0.5 points more than fixed CPAP. For compliance,
there was a statistically significant difference of 11 minutes per
night also favoring APAP compared to fixed CPAP.
Recommendations
• If patients are carefully selected, auto-PAP-derived optimal CPAP
pressure compares favorably to PSG-derived CPAP determinations
• Exclude comorbidities (CHF, COPD, CSA, hypoventilation syndromes)
from such treatment strategies
• Auto-PAP therapy may provide cost savings
• Formal cost-effectiveness studies need to be performed with RCTs or across
healthcare system databases.
• Comparative-effectiveness of auto-PAP and PSG-based management
strategies requires further study.
Adaptive Servo-Ventilation (ASV) for
CSAS
• Practice Parameter 2012 Standard: ASV targeted to normalize the AHI
is indicated for the treatment of CSAS related to CHF
• Field Safety Notice issued by ResMed May 2015
• AASM advised physicians to stop prescribing ASV
• To treat central sleep apnea
• Symptomatic heart failure with LVEF <45%.
Adaptive Servo-Ventilation (ASV) for CSAS
FMCSA
• Gives little guidance to Medical Examiner
• HST to APAP acceptable for treatment, and compliance monitoring
• Needs to meet EBM for clinical quality and safety
What Is Ahead?
• Smaller devices
• Convenient battery backup work on one charge for days
• Smaller lighter humidifiers
• Incorporation of a technology that doesn’t require daily patientinitiated water changes
• Easier ability to clean, sterilize, and maintain the device accordingly
• Routine sleep screenings as a preventative therapy
• Smarter algorithms and sensor features
• The “on button” - care delivery is changing for everyone
Sleep Health Prevention
•
Conclusion…
EBM – Go by the book, rest assured.
Questions?
Download